Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Pick the Right Web-based Degree Program - 221 Incredibly Entertaining Contemplations To Observe Consistently
- 3European Travel Objections for 2024
- 4The Most Notable Design Brands of the 21st Hundred years
- 523 Most Amusing Messages At any point Sent Among Kids and Their Folks
- 'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say
- Figure out How to Assess the Unwavering quality of SUVs for Seniors
- Heavy rain, floods kill at least 45 people in Afghanistan, Pakistan
- Foot fossil discovery could reshape human evolutionary history
- Shooting of MIT professor Nuno Loureiro has police searching for a suspect
- Israel faces widespread condemnation as NGO ban comes into effect
- Savvy Tips for Seniors Hyundai IONIQ EV
- Unsold Rams May Be Less expensive Than You Suspect
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
